Lakefront Biotherapeutics NV (LKFT)

NASDAQ: LKFT · Real-Time Price · USD

27.83

-0.19 (-0.68%)

At close: Jun 8, 2026, 4:00 PM EDT

27.81

-0.02 (-0.07%)

After-hours: Jun 8, 2026, 6:47 PM EDT

LKFT Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,092	1,166	316.42	287	277.38	280.46
Revenue Growth (YoY)	234.71%	268.41%	10.25%	3.47%	-1.10%	-47.11%
Cost of Revenue	20.81	29.74	34.86	-	-	-
Gross Profit	1,071	1,136	281.56	287	277.38	280.46
Selling, General & Admin	145.14	153.43	134.44	133.97	138.64	131.52
Research & Development	307.63	459.42	335.46	241.29	269.8	320.5
Other Operating Expenses	23.36	228.11	-	-	-	-
Total Operating Expenses	476.13	840.97	469.9	375.26	408.43	452.02
Operating Income	390.04	295.04	-188.34	-88.26	-131.06	-171.57
Interest Income	49.04	48.05	91.13	80.25	18.56	3.06
Interest Expense	-2.22	-2.86	-1.67	-2.61	-9.85	-12.35
Other Non-Operating Income (Expense)	34.33	-39.36	95.8	16.25	51.5	61.46
Total Non-Operating Income (Expense)	81.15	5.83	185.25	93.89	60.21	52.17
Pretax Income	471.19	300.87	-3.09	5.63	-70.85	-119.4
Provision for Income Taxes	16.74	18.62	1.8	-9.61	-0.57	-1.39
Net Income	454.46	282.25	-4.89	15.24	-70.28	-118.01
Earnings From Discontinued Operations	0.85	1.39	75.36	215.69	-146.57	17.56
Net Income to Common	488.78	320.88	74.08	211.7	-217.99	-103.23
Net Income Growth	-	333.15%	-65.01%	-	-	-
Shares Outstanding (Basic)	66	66	66	66	66	66
Shares Outstanding (Diluted)	66	66	66	66	66	66
Shares Change (YoY)	0.02%	-	0.02%	0.28%	0.30%	0.65%
EPS (Basic)	7.42	4.87	1.12	3.21	-3.32	-1.58
EPS (Diluted)	7.42	4.87	1.12	3.21	-3.32	-1.58
EPS Growth	-	334.82%	-65.11%	-	-	-
Shares Outstanding	65.9	65.9	65.9	65.9	65.84	65.55
Free Cash Flow	-310.33	-271.16	-336.75	-424.68	-527.93	-558.03
Free Cash Flow Per Share	-4.71	-4.11	-5.11	-6.45	-8.04	-8.52
Gross Margin	98.09%	97.45%	88.98%	100.00%	100.00%	100.00%
Operating Margin	35.73%	25.31%	-59.52%	-30.75%	-47.25%	-61.17%
Profit Margin	41.63%	24.21%	-1.54%	5.31%	-25.34%	-42.08%
FCF Margin	-28.43%	-23.26%	-106.42%	-147.97%	-190.33%	-198.97%
EBITDA	427.66	350.91	-188.34	-44.62	-65.49	-136.93
EBITDA Margin	39.17%	30.10%	-59.52%	-15.55%	-23.61%	-48.82%
EBIT	390.04	295.04	-188.34	-88.26	-131.06	-171.57
EBIT Margin	35.73%	25.31%	-59.52%	-30.75%	-47.25%	-61.17%
Effective Tax Rate	3.55%	6.19%	-58.44%	-170.90%	0.81%	1.16%

SEC Filings: 10-K · 10-Q